Physician profile
Laura Lloyd
NPI 1750374997
$2,421.37
in general payments reported to CMS, 2019-2025
16 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $164 · 2021: $251 · 2022: $367 · 2023: $326 · 2024: $458 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $386.10 | 2023-2024 | |
| Horizon Therapeutics Plc | $310.49 | 2020-2022 | |
| Amgen INC. | $258.12 | 2024-2025 | Krystexxa |
| Kerecis Limited | $234.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $229.24 | 2024 | Intellis Adaptivestim |
| Stryker Corporation | $206.35 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $160.42 | 2022-2025 | Nuzyra |
| Heron Therapeutics, INC. | $125.00 | 2021 | |
| Triad Life Sciences INC. | $100.40 | 2022 | |
| Zimmer Biomet Holdings, INC. | $94.13 | 2019 | |
| Melinta Therapeutics, LLC | $83.14 | 2019 | |
| Ani Pharmaceuticals, INC. | $64.85 | 2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $55.61 | 2025 | |
| Nevro Corp. | $51.28 | 2022-2023 | Senza |
| Cumberland Pharmaceuticals, INC. | $36.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $25.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.